Levodopa Inhalation Powder Articles & Analysis
2 news found
(Nasdaq: ACOR) today announced that Esteve Pharmaceuticals GmbH has launched INBRIJA® 33 mg (levodopa inhalation powder, hard capsules) in Germany. INBRIJA is indicated in the EU for the intermittent treatment of episodic motor fluctuations (OFF episodes) in adult patients with Parkinson’s disease treated with a ...
The pulmonary administration of levodopa results in faster and more reliable systemic absorption, which makes it a promising alternative for the rescue treatment of OFF episodes. As the first levodopa dry powder inhalers are in development or registered, it will become clear in the nearby future whether inhaled ...